FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval

Submitted by admin on July 14, 2021 - 10:37pm

Source:

Stat

News Tags:

Janet Woodcock

FDA

Biogen

Aduhelm

Alzheimer's disease

Headline:

FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval

snippet:

Acting Food and Drug Administration Commissioner Janet Woodcock acknowledged on Wednesday her agency may have misstepped in its handling of its polarizing approval of a new Alzheimer’s drug.

Search form

You are here

FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval

FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval